OMRIVY
Live / Allowed — Third extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Dec 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98328201
- Mark type
- Word mark
- Filed
- 22 Dec 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Sonali S. Srivastava
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscience
Owner
- Cerevel Therapeutics, LLC, North Chicago, IL, US
- Cerevel Therapeutics, LLC, Cambridge, MA, US
Prosecution history
- 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 3 GRANTED
- 09 Mar 2026 — SOU EXTENSION 3 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2025 — SOU EXTENSION 2 GRANTED
- 10 Oct 2025 — SOU EXTENSION 2 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2025 — SOU EXTENSION 1 GRANTED
- 28 Apr 2025 — SOU EXTENSION 1 FILED
- 28 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED